Post-IPO Equity Medical Companies

Cheelcare develops robotic mobility devices and accessories for people with disabilities.

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.

Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

Picard Medical brings to the table technical and commercial expertise.

Nexalin Technology develops transcranial electrical stimulation equipment for the treatment of anxiety, insomnia, and depression.

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

Polaryx Therapeutics is a biopharmaceutical company that provides molecule therapeutics development and clinical trial services.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.

Audientes is engaged in the design and development of accessible and affordable hearing aids for hearing impaired people.

BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies.

Polarean is manufacturer and service provider for noble gas polarizer devices and ancillary instruments.

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.

Optimi Health is a supplier of GMP psychedelic compounds.

Redx Pharma is a drug discovery and development company.

WELL Health Technologies is the owner and operator of a portfolio of Primary Healthcare facilities.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Assure Neuromonitoring is a medical company providing outsourced intraoperative neurophysiological monitoring and neurology services.

QT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.